With demand vastly outweighing supply, President Biden should make sure the two treatments okayed by the Food and Drug Administration last month, Merck’s Molnupiravir and Pfizer’s Paxlovid, go where they’re needed most, the New York Democrat and Senate Majority Leader said.
Read more here New York Daily News